RecruitingNCT07117344
Biomarkers in Ankylosing Spondylitis
"Progranulin in Ankylosing Spondylitis Patients: A Potential Biomarker?"
Sponsor
Kirsehir Ahi Evran Universitesi
Enrollment
160 participants
Start Date
Jan 15, 2026
Study Type
OBSERVATIONAL
Conditions
Summary
In this study, we aimed to compare serum PGRN(progranulin) and TNF-α levels in AS patients with healthy controls and to determine the relationship between TNF-α inhibitor use and PGRN levels in AS patients.
Eligibility
Min Age: 20 YearsMax Age: 65 Years
Inclusion Criteria3
- Between the ages of 20-65
- Signing the informed consent form
- Axial spondyloarthropathy diagnosis according to ASAS 2009 criteria
Exclusion Criteria4
- Pregnancy or lactation
- Having signs of acute or chronic infection
- Presence of malignancy
- Having concurrent secondary rheumatic disease other than Axial Spondyloarthropathy
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07117344